|
|
Please
login
to be able to add spectra, identifiers, links and publications.
|
|
|
ChemSpider ID: |
12773
|
|
Empirical Formula: |
C46H58N4O9
|
|
Molecular Weight: |
810.9741
|
|
Nominal Mass: |
810
Da
|
|
Average Mass: |
810.9741
Da
|
|
Monoisotopic Mass: |
810.420379
Da
|
|
|
|
Systematic Name: |
|
|
SMILES: |
O=C(OC)[C@]4(c2c(c1ccccc1n2)CCN3C[C@](O)(CC)C[C@H](C3)C4)c5c(OC)cc6c(c5)[C@@]89[C@@H](N6C)[C@@](O)(C(=O)OC)[C@H](OC(=O)C)[C@@]7(/C=C\CN([C@@H]78)CC9)CC
|
|
InChI: |
InChI=1/C46H58N4O9/c1-8-42(54)23-28-24-45(40(52)57-6,36-30(15-19-49(25-28)26-42)29-13-10-11-14-33(29)47-36)32-21-31-34(22-35(32)56-5)48(4)38-44(31)17-20-50-18-12-16-43(9-2,37(44)50)39(59-27(3)51)46(38,55)41(53)58-7/h10-14,16,21-22,28,37-39,47,54-55H,8-9,15,17-20,23-26H2,1-7H3/t28-,37-,38+,39+,42-,43+,44+,45-,46-/m0/s1
|
|
InChIKey: |
JXLYSJRDGCGARV-CFWMRBGOBT
|
Description
A synthetic route to vinblastine and its related analogs with an ethynyl group, which features a stereoselective coupling of an 11-membered key intermediate with vindoline has been described in this paper. See: DOI: 10.1021/ol702040y
Tags
|
Natural Products
|
|
Synthesis
|
Links & References
|
|
|
|
Miyazaki, T., Yokoshima, S., Simizu, S., Osada, H. Tokuyama, H. and Fukuyama, T..
Synthesis of (+)-Vinblastine and Its Analogues, Org. Lett., 2007, 9 (23), 4737 -4740
|
|
|
Validated by Experts, Validated by Users, Non-Validated, Removed by Users,
Redirected by Users, Redirect Approved by Experts
212-734-0
[EINECS/ELINCS]
865-21-4
[RN]
EXAL
Leurosidine
Methyl (3aR,4R,5aR,10bR,13aR)-4-acetoxy-3a-ethyl-9-[(13S,15R,17S)-17-ethyl-17-hydroxy-13-(methoxycarbonyl)-1,11-diazatetracyclo[13.3.1.0~4,12~.0~5,10~]nonadeca-4(12),5,7,9-tetraen-13-yl]-5-hydroxy-8-methoxy-6-methyl-3a,4,5,5a,6,11,12,13a-octahydro-1H-indolizino[8,1-cd]carbazole-5-carboxylate
VELBAN
[Wiki]
vincaleukoblastine, (2'beta,4'beta)-
(2ALPHA,2'BETA,3BETA,4ALPHA,5BETA)-VINCALEUKOBLASTINE
(3aR-(3aalpha,4beta,5beta,5abeta,9(3R*,5S*,7R*,9S*),10bR*,13aalpha))-methyl 4-(acetyloxy)-3a-ethyl-9-(5-ethyl-1,4,5,6,7,8,9,10-octahydro-5-hydroxy-9-(methoxycarbonyl)-2H-3,7-methanoazacycloundecino(5,4-b)indol-9-yl)-3a,4,5,5a,6,11,12,13a-octahydro-5-hydroxy-8-methoxy-6-methyl-1H-indolizino(8,1-cd)carbazole-5-carboxylate
143-67-9 [RN]
More...
1H-Indolizino(8,1-cd)carbazole-5-carboxylic acid, 4-(acetyloxy)-3a-ethyl-9-(5-ethyl-1,4,5,6,7,8,9,10-octahydro-5-hydroxy-9-(methoxycarbonyl)-2H-3,7-methanoazacycloundecino(5,4-b)indol-9-yl)-3a,4,5,5a,6,11,12,13a-octahydro-5-hydroxy-8-methoxy-6-methyl-, methyl ester, (3aR-(3aalpha,4beta,5beta,5abeta,9(3R*,5S*,7R*,9S*),10bR*,13aalpha))-
29060-LE
NDC 0002-1452-01
Nincaluicolflastine
Rozevin
Velbe
Vinblastin
Vinblastina [DCIT]
Vinblastine
[Wiki]
Vinblastinum
[Latin]
Vinblastinum [INN-Latin]
Vincaleucoblastine
Vincaleukoblastine
Vincoblastine
VLB
VR-8
Less...
Validated by Experts, Validated by Users, Non-Validated, Removed by Users,
Redirected by Users, Redirect Approved by Experts
|
LogP: |
ACD/LogP:
4.18
XLogP:
3.90
|
# of Rule of 5 Violations: |
2
|
|
ACD/LogD (pH 5.5): |
1.73
|
ACD/LogD (pH 7.4): |
3.69
|
|
ACD/BCF (pH 5.5): |
3.16
|
ACD/BCF (pH 7.4): |
284.81
|
|
ACD/KOC (pH 5.5): |
16
|
ACD/KOC (pH 7.4): |
1440.47
|
|
#H bond acceptors: |
13
|
#H bond donors: |
3
|
|
#Freely Rotating Bonds: |
12
|
Polar Surface Area: |
121.24
Å2
|
|
Index of Refraction: |
1.671
|
Molar Refractivity: |
220.74
cm3
|
|
Molar Volume: |
590
cm3
|
Polarizability: |
87.5
10-24cm3
|
|
Surface Tension: |
70.9
dyne/cm
|
Density: |
1.37
g/cm3
|
|
Flash Point: |
°C
|
Enthalpy of Vaporization: |
kJ/mol
|
|
Boiling Point: |
°C at 760 mmHg
|
Vapour Pressure: |
mmHg at 25°C
|
Descriptors:
0, 0, 0, 1, 0, 0, 0, 9, 3, 0, 2, 4, 31, 6, 16, 2, 15, 7, 3, 1, 2, 0, 0, 0
| Category | Target | PDB Code | LASSO Score |
| Metalloenzymes | ACE, angiotensin-converting enzyme; | 1o86 | 0.00 |
| Other Enzymes | AChE, acetylcholinesterase; | 1eve | 0.00 |
| Metalloenzymes | ADA, adenosine deaminase; | 1stw | 0.00 |
| Other Enzymes | AmpC, AmpC beta-lactamase; | 1xgj | 0.00 |
| Nuclear Hormone Receptors | AR, androgen receptor; | 1xq2 | 0.00 |
| Kinases | CDK2, cyclindependent kinase 2; | 1ckp | 0.00 |
| Metalloenzymes | COMT, catechol O-methyltransferase; | 1h1d | 0.00 |
| Other Enzymes | cyclooxygenase-2 | 1cx2 | 0.00 |
| Folate Enzymes | DHFR, dihydrofolate reductase; | 3dfr | 0.00 |
| Kinases | EGFr, epidermal growth factor receptor; | 1m17 | 0.00 |
| Nuclear Hormone Receptors | ER, estrogen receptor; agonist | 1l2i | 0.00 |
| Kinases | FGFr1, fibroblast growth factor receptor kinase; | 1agw | 0.00 |
| Serine Proteases | FXa, factor Xa; | 1f0r | 0.00 |
| Folate Enzymes | GART, glycinamide ribonucleotide transformylase; | 1c2t | 0.00 |
| Other Enzymes | GPB, glycogen phosphorylase â; | 1a8i | 0.00 |
| Other Enzymes | HIVPR, HIV protease; | 1hpx | 0.01 |
| Other Enzymes | HIVRT, HIV reverse transcriptase; | 1rt1 | 0.00 |
| Other Enzymes | HMGR, hydroxymethylglutaryl-CoA reductase; | 1hw8 | 0.01 |
| Kinases | HSP90, human heat shock protein 90; | 1uy6 | 0.00 |
| Nuclear Hormone Receptors | MR, mineralocorticoid receptor; | 2aa2 | 0.01 |
| Other Enzymes | NA, neuraminidase; | 1a4g | 0.00 |
| Kinases | P38 MAP, P38 mitogen activated protein; | 1kv2 | 0.00 |
| Other Enzymes | PARP, poly(ADP-ribose) polymerase; | 1efy | 0.01 |
| Metalloenzymes | PDE5, phosphodiesterase 5; | 1xp0 | 0.01 |
| Kinases | PDGFrb, platelet derived growth factor receptor kinase; | | 0.00 |
| Other Enzymes | PNP, purine nucleoside phosphorylase; | 1b8o | 0.00 |
| Nuclear Hormone Receptors | PPARg, peroxisome proliferator activated receptor ç; | 1fm9 | 0.03 |
| Nuclear Hormone Receptors | PR, progesterone receptor; | 1sr7 | 0.00 |
| Nuclear Hormone Receptors | RXRa, retinoic X receptor R; | 1mvc | 0.00 |
| Other Enzymes | SAHH, S-adenosyl-homocysteine hydrolase; | 1a7a | 0.00 |
| Kinases | SRC, tyrosine kinase SRC; | 2src | 0.01 |
| Serine Proteases | Thrombin | 1ba8 | 0.01 |
| Kinases | TK, thymidine kinase; | 1kim | 0.00 |
| Kinases | VEGFr2, vascular endothelial growth factor receptor; | 1vr2 | 0.00 |
|
|